| Manjiri S Lele, MD | |
|
4545 R Street, Lincoln, NE 68503-3799 | |
| (402) 465-4545 | |
| Not Available |
| Full Name | Manjiri S Lele |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 4545 R Street, Lincoln, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710164074 | NPI | - | NPPES |
| 24115 | Other | NE | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 24115 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Manjiri S Lele, MD 4545 R St, Lincoln, NE 68503-3799 Ph: (402) 465-4545 | Manjiri S Lele, MD 4545 R Street, Lincoln, NE 68503-3799 Ph: (402) 465-4545 |
News Archive
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,759,304, entitled "Targeting Complement Factor H For Treatment of Diseases", covering the composition of matter for its lead product candidate, TT30, a novel fusion protein that selectively binds to complement activated cells to locally regulate the complement system.
Researchers from the University of Zurich have now studied in detail what sportsmen and women know from experience: The head plays a key role in tiring endurance performances.
French scientists have found a drug they say tricks the body into burning off fat - and it even works on a high-fat diet.
City of Hope, a world-renowned independent cancer research and treatment center, and its affiliate, Translational Genomics Research Institute (TGen), have announced a letter of intent to develop a state-of-the-art cell therapy manufacturing facility in the Phoenix Metropolitan Area, a move that would improve the speed at which stem cell research and cancer treatment is delivered.
UCB announced today that the U.S. Food and Drug Administration has approved Cimzia (certolizumab pegol) for the treatment of adult patients with active psoriatic arthritis.
› Verified 2 days ago
Dr. Aina Inese Silenieks, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 5440 South Street, Suite 200, Lincoln, NE 68506 Phone: 402-465-1900 Fax: 402-465-1940 | |
Dr. Tyler Ryan Teichmeier, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 5440 South St Ste 200, Lincoln, NE 68506 Phone: 402-465-1900 | |
Matthias I Okoye, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 600 S 70th St, Lincoln, NE 68510 Phone: 402-486-3447 Fax: 402-486-3477 | |
Dr. Deborah Kay Davidson, DO Pathology Medicare: Not Enrolled in Medicare Practice Location: 5440 South Street, Suite 200, Lincoln, NE 68506 Phone: 402-465-1900 Fax: 402-465-1940 | |
Jon R Steinhauer, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5440 South St Ste 200, Lincoln, NE 68506 Phone: 402-465-1900 Fax: 402-465-1940 | |
Dr. Neil E. Fuehrer, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5440 South St Ste 200, Lincoln, NE 68506 Phone: 402-465-1900 Fax: 402-465-1973 | |
Dr. Charles Meehan Reese, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5440 South Street, Suite 200, Lincoln, NE 68506 Phone: 402-465-1900 Fax: 402-465-1940 |